Rare diseases
Investigational molecules
Locations
A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
The NetherlandsStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
The NetherlandsStudy on the Effects of Povorcitinib for Patients with Prurigo Nodularis
The NetherlandsStudy on Durvalumab and FLOT Chemotherapy for Patients with Resectable Gastric and Gastroesophageal Cancer
The NetherlandsStudy on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)
The NetherlandsStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
The NetherlandsStudy on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma
The NetherlandsStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
The NetherlandsStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
The NetherlandsStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
The NetherlandsSacituzumab Tirumotecan in Recurrent or Metastatic Cervical Cancer After Platinum Chemotherapy and Anti-PD-L1 or Anti-PD-1 Therapy
The NetherlandsStudy of tuvusertib combined with niraparib or lartesertib for patients with ovarian cancer that worsened after previous PARP inhibitor treatment
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
